(Q36448288)

14 August 2017

1 reference

title

The importance of residual renal function in dialysis patients (English)

1 reference

14 August 2017

0 references

0 references

A Y-M Wang

1

1 reference

14 August 2017

K-N Lai

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

69

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

1726-1732

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000382

14 August 2017

exact match

0 references

cites work

Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Peritoneal dialysis adequacy and risk of death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Residual renal function and mortality risk in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Effect of fluid and sodium removal on mortality in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Long-term changes in left ventricular hypertrophy after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients: A Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Quiz page. HIV-associated nephropathy is the overwhelmingly most likely diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Inflammation, Residual Kidney Function, and Cardiac Hypertrophy Are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Associations between circulating inflammatory markers and residual renal function in CRF patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Resting Energy Expenditure and Subsequent Mortality Risk in Peritoneal Dialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Beta-2-microglobulin generation rate and clearance rate in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

The influence of automated peritoneal dialysis on the decrease in residual renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

The role of APD in the improvement of outcomes in an ESRD program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Nephrotoxic effects in high-risk patients undergoing angiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Acetylcysteine for prevention of contrast nephropathy: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Empirical aminoglycosides for peritonitis do not affect residual renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Strict volume control normalizes hypertension in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000382

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000382

1 reference

release_i4qh34vr3jhjrbcabenyk2umxa

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i4qh34vr3jhjrbcabenyk2umxa

24 November 2022

mapped directly with Wikidata item

1 reference